Insulin Therapy Center

Diabetes in Control Publisher Steve Freed meets with Dr. Richard Bergman at the 75th ADA Scientific Sessions in Boston. In this first installment, Dr. Bergman shares his start in diabetes research and explains the high points of his presentation, Comparative Methods for Assessment of Insulin Sensitivity: Oral Vs. Intravenous. Dr. Richard Bergman is the founder and director of Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes.

Patients with highest fasting insulin had almost threefold higher risk of hypertension, left ventricular hypertrophy.

In this week's Homerun Slides, the addition of liraglutide to insulin degludec.

In this week's Homerun Slides, the study and results of the addition of insulin detemir to Liraglutide treatment of type 2 diabetes.

In a follow-up visit for an insulin-requiring patient with type 2 DM, it was obvious that the management of his DM had deteriorated. According to his girlfriend, this patient ate only 1-2 meals a day, but they tended to be high-carbohydrate meals. We reviewed the patient's insulin regimem in detail and ascertained that he was using the sliding scale correctly.

Findings suggest that helping patients respond effectively to eating disorder symptoms might decrease insulin restriction.

New study suggests that in hospital patients with T2DM, premixed insulin provides similar glycemic control as a basal-bolus insulin regimen.

In this week's Homerun Slides, the effectiveness of Lixisenatide when added to basal insulin, and strategies for avoiding or minimizing the GI effects of GLP-1.

Patient history of CVD, higher A1C factored into risk.

Findings suggest treatment may reduce urine albumin creatinine ratio in T1DM.